Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03591016
Other study ID # IRB18-00495
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2, 2018
Est. completion date December 8, 2020

Study information

Verified date February 2021
Source Nationwide Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational study only, where number of attempts to establish peripheral IV catheter placement will be recorded during procedures in all anesthetizing location on the main campus of Nationwide Children's Hospital.


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date December 8, 2020
Est. primary completion date December 8, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Patients 0-18 years of age - Having surgery at Nationwide Children's Hospital Exclusion Criteria: - Pre-existing IV upon arrival to the operating room

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Recording number of IV attempts
Recording number of IV attempts in the operating room

Locations

Country Name City State
United States Nationwide Children's Hospital Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ralph Beltran

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time it takes to insert an IV between 1 to 30 minutes
Secondary Anticipated difficulty Provider's prediction of how difficult it will be to start the IV on a Likert scale of 1-10, with 10 being the most difficult. Baseline
Secondary Actual difficulty Provider's assessment of how difficult the actual IV insertion was on the same Likert scale. between 1 to 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT03181542 - Infra Red Vein Visualization: Efficacy vs. Standard Technique N/A
Completed NCT00740727 - EASI Access II --- Follow-up Study to the EASI Access Trial Phase 1